FiercePharma

Dogs Merck Animal Health Announces FDA Approval of BRAVECTO™ (fluralaner)

First Chewable Tablet for Dogs Effective for 12 Weeks* Against Fleas and Ticks SUMMIT, NJ, May 20, 2014 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today ...
Business Wire

Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs

MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
Pharm Exec

Merck Animal Health’s Bravecto Quantum (Fluralaner for Extended-Release Injectable Suspension) Receives FDA Approval

Bravecto Quantum becomes first FDA approved drug to protect dogs against fleas and ticks for 8 to 12 months. Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick ...
elEconomista

MSD Animal Health Receives Marketing Approval from European Medicines Agency for BRAVECTO? (fluralaner) Spot-On Solution for Cats and Dogs

“Approval of BRAVECTO Spot-On builds on the strong foundation and body of scientific evidence that we have established with our chewable tablet for dogs, the oral flea and tick product available today ...
Chicago Tribune

Which flea and tick medicine is best for dogs?

Dog owners know the importance of regular veterinarian checkups and vaccinations for the health of their beloved pets. However, don’t forget about some of the other medications that dogs need to ...
FiercePharma

Merck Animal Health Announces FDA Approval of BRAVECTO™ (fluralaner)

SUMMIT, N.J., May 20, 2014 /PRNewswire/ -- Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced the U.S. Food and Drug Administration's approval of ...